When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HOOK - Hookipa Gains FDA Signal To Begin HPV-Cancer Drug; Allows For Catalyst In Late 2020
HOOKIPA Pharma Inc.
Hookipa Pharma (HOOK) announced that an IND was cleared by the FDA so that it could begin its phase 1/2 study treating patients with Human Papilloma Virus ((HPV))-positive cancers. The reason why this latest development is important for the biotech is because it will be the first immuno-oncology program from the pipeline. As a catalyst, investors have data to look forward to approximately 1-year from now because Hookipa intends to release preliminary data in late 2020/early 2021. Another promising aspect is that this biotech has partnered with Gilead Sciences (GILD) to